HORIZON THERAPEUTICS, LLC v. PAR PHARMACEUTICAL, INC. > Summary
Court Case Number 2:17-cv-05901
Filing Date Aug 8, 2017
Termination Date Sep 26, 2018
Court New Jersey District Court
Status Dismissed - Voluntarily
JudgesKevin McNulty, Michael A. Hammer
Plaintiff
Defendant
Plaintiff Attorneys
16Horizon Therapeutics
Attorney Name: John E. Flaherty
McCarter & English
Horizon Therapeutics
Attorney Name: Ravin R. Patel
McCarter & English
Horizon Therapeutics
Attorney Name: Robert F. Green
Green, Griffith & Associates LLP
Horizon Therapeutics
Attorney Name: Emer L. Simic
Green, Griffith & Associates LLP
Horizon Therapeutics
Attorney Name: Ann K. Jubelirer
Green, Griffith & Associates LLP
Horizon Therapeutics
Attorney Name: Rachel C. Bell
Green, Griffith & Associates LLP
Horizon Therapeutics
Attorney Name: Caryn Borg-Breen
Green, Griffith & Associates LLP
Horizon Therapeutics
Attorney Name: Jessica Tyrus Mackay
Green, Griffith & Associates LLP
Horizon Therapeutics
Attorney Name: Benjamin D. Witte
Green, Griffith & Associates LLP
Horizon Therapeutics
Attorney Name: Vernon Reid. Sutton
Baylor College of Medicine
Attorney Name: Jessica Tyrus Mackay
Attorney Name: Ann K. Jubelirer
Attorney Name: Ann K. Jubelirer
Attorney Name: Guillermo C. Artiles
Attorney Name: Ann K. Jubelirer
Attorney Name: John E. Flaherty
Defendant Attorneys
6Par Pharmaceutical, Inc.
Attorney Name: Aziz Burgy
Axinn Veltrop & Harkrider
Par Pharmaceutical, Inc.
Attorney Name: William C. Rose
Axinn Veltrop & Harkrider
Par Pharmaceutical, Inc.
Attorney Name: David H. Silverstein
Axinn Veltrop & Harkrider
Par Pharmaceutical, Inc.
Attorney Name: Ricardo Camposanto
Axinn Veltrop & Harkrider
Par Pharmaceutical, Inc.
Attorney Name: Christopher M. Gallo
Axinn Veltrop & Harkrider
Counter Defendant
2Horizon Therapeutics
Attorney Name: John E. Flaherty
McCarter & English
Horizon Therapeutics
Attorney Name: Ravin R. Patel
McCarter & English
Counter Claimant
Cause
35:271 Patent Infringement
Related Patents
Doc No | Title | Issue date |
---|---|---|
09561197 | Methods of therapeutic monitoring of phenylacetic acid prodrugs | Feb 7, 2017 |